Chemoinformaics analysis of Aristololactam A-II
Molecular Weight | 265.268 | nRot | 1 |
Heavy Atom Molecular Weight | 254.18 | nRig | 20 |
Exact Molecular Weight | 265.074 | nRing | 4 |
Solubility: LogS | -6.447 | nHRing | 1 |
Solubility: LogP | 3.848 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 3 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
nHA | 3 | APOL | 37.5607 |
nHD | 2 | BPOL | 14.2093 |
QED | 0.664 |
Synth | 2.566 |
Natural Product Likeliness | 1.259 |
NR-PPAR-gamma | 0.951 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.004 |
Pgp-sub | 0.139 |
HIA | 0.01 |
CACO-2 | -5.042 |
MDCK | 0.0000106 |
BBB | 0.078 |
PPB | 0.947196 |
VDSS | 0.6 |
FU | 0.0618021 |
CYP1A2-inh | 0.982 |
CYP1A2-sub | 0.879 |
CYP2c19-inh | 0.262 |
CYP2c19-sub | 0.137 |
CYP2c9-inh | 0.634 |
CYP2c9-sub | 0.858 |
CYP2d6-inh | 0.703 |
CYP2d6-sub | 0.278 |
CYP3a4-inh | 0.389 |
CYP3a4-sub | 0.103 |
CL | 2.489 |
T12 | 0.417 |
hERG | 0.049 |
Ames | 0.804 |
ROA | 0.035 |
SkinSen | 0.926 |
Carcinogencity | 0.706 |
EI | 0.894 |
Respiratory | 0.825 |
NR-Aromatase | 0.128 |
Antiviral | Yes |
Prediction | 0.691472 |